BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12578393)

  • 1. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
    Havener JM; Nick McElhinny SA; Bassett E; Gauger M; Ramsden DA; Chaney SG
    Biochemistry; 2003 Feb; 42(6):1777-88. PubMed ID: 12578393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
    Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
    Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
    Chaney SG; Campbell SL; Bassett E; Wu Y
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.
    Vaisman A; Chaney SG
    J Biol Chem; 2000 Apr; 275(17):13017-25. PubMed ID: 10777605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
    Vaisman A; Masutani C; Hanaoka F; Chaney SG
    Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
    Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
    DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
    J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
    Vaisman A; Lim SE; Patrick SM; Copeland WC; Hinkle DC; Turchi JJ; Chaney SG
    Biochemistry; 1999 Aug; 38(34):11026-39. PubMed ID: 10460158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of base sequence context on translesion synthesis past a bulky (+)-trans-anti-B[a]P-N2-dG lesion catalyzed by the Y-family polymerase pol kappa.
    Huang X; Kolbanovskiy A; Wu X; Zhang Y; Wang Z; Zhuang P; Amin S; Geacintov NE
    Biochemistry; 2003 Mar; 42(8):2456-66. PubMed ID: 12600213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts.
    Vaisman A; Warren MW; Chaney SG
    J Biol Chem; 2001 Jun; 276(22):18999-9005. PubMed ID: 11259423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
    Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
    Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of platinum-DNA adduct repair.
    Chaney SG; Vaisman A
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translesion synthesis past equine estrogen-derived 2'-deoxycytidine DNA adducts by human DNA polymerases eta and kappa.
    Suzuki N; Yasui M; Santosh Laxmi YR; Ohmori H; Hanaoka F; Shibutani S
    Biochemistry; 2004 Sep; 43(35):11312-20. PubMed ID: 15366941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerases.
    Rechkoblit O; Zhang Y; Guo D; Wang Z; Amin S; Krzeminsky J; Louneva N; Geacintov NE
    J Biol Chem; 2002 Aug; 277(34):30488-94. PubMed ID: 12063247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the sequence-dependent effects of platinum-DNA adducts.
    Ramachandran S; Temple BR; Chaney SG; Dokholyan NV
    Nucleic Acids Res; 2009 May; 37(8):2434-48. PubMed ID: 19255091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adduct size limits efficient and error-free bypass across bulky N2-guanine DNA lesions by human DNA polymerase eta.
    Choi JY; Guengerich FP
    J Mol Biol; 2005 Sep; 352(1):72-90. PubMed ID: 16061253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
    Alt A; Lammens K; Chiocchini C; Lammens A; Pieck JC; Kuch D; Hopfner KP; Carell T
    Science; 2007 Nov; 318(5852):967-70. PubMed ID: 17991862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miscoding properties of 6alpha- and 6beta-diastereoisomers of the N(2)-(estradiol-6-yl)-2'-deoxyguanosine DNA adduct by Y-family human DNA polymerases.
    Poon K; Itoh S; Suzuki N; Laxmi YR; Yoshizawa I; Shibutani S
    Biochemistry; 2008 Jun; 47(25):6695-701. PubMed ID: 18512958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamics.
    Sharma S; Gong P; Temple B; Bhattacharyya D; Dokholyan NV; Chaney SG
    J Mol Biol; 2007 Nov; 373(5):1123-40. PubMed ID: 17900616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
    Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
    Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.